Status:
COMPLETED
Clomiphene Plus N-acetyl Cysteine for Induction of Ovulation in Newly Diagnosed Pcos.
Lead Sponsor:
Woman's Health University Hospital, Egypt
Conditions:
PCOS
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting approximately 6-10% of women of reproductive age. Anovulation, infertility and hyperandrogenism often co-exist...
Detailed Description
NAC has been used effectively as an adjuvant to clomiphene citrate (CC) for ovulation induction in CC-resistant women with PCOS . Because it is an insulin sensitizer, NAC was proposed as an adjuvant ...
Eligibility Criteria
Inclusion
- PCOS diagnosed by Rotterdam's criteria
Exclusion
- previous induction of ovulation male factoe infertility tubal factor infertility uterine factor infertility
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01896492
Start Date
January 1 2011
End Date
June 1 2013
Last Update
August 12 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.